Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit

28 Quellenangaben (Web of Science)

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

@article{f903cdec2ff84ee2a29e62b82e684e44,

title = "Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.",

author = "Kinga Szurian and Karl Kashofer and Bernadette Liegl-Atzwanger",

year = "2017",

doi = "10.1159/000478662",

language = "English",

journal = "Pathobiology",

issn = "1015-2008",

publisher = "S. Karger AG",

}

TY - JOUR

T1 - Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.

AU - Kashofer, Karl

A2 - Szurian, Kinga

A2 - Liegl-Atzwanger, Bernadette

PY - 2017

Y1 - 2017

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000423975700004

UR - https://pubmed.ncbi.nlm.nih.gov/28817827

U2 - 10.1159/000478662

DO - 10.1159/000478662

M3 - Review

C2 - 28817827

SN - 1015-2008

JO - Pathobiology

JF - Pathobiology

ER -